Breaking News
Get 40% Off 0
👀 👁 🧿 All eyes on Biogen, up +4,56% after posting earnings. Our AI picked it in March 2024.
Which stocks will surge next?
Unlock AI-picked Stocks
Close

Adamas Pharma (ADMS)

Create Alert
New!
Create Alert
Website
  • As an alert notification
  • To use this feature, make sure you are signed-in to your account
Mobile App
  • To use this feature, make sure you are signed-in to your account
  • Make sure you are signed-in with the same user profile

Condition

Frequency

Once
%

Frequency

Frequency

Follow Adamas Pharmaceuticals Inc's earnings

Delivery Method

Status

Add to/Remove from Watchlist Add to Watchlist
Add to Watchlist
Add Position

Position added successfully to:

Please name your holdings portfolio
 
Adamas Pharmaceuticals Inc historical data, for real-time data please try another search
8.220 +0.000    +0.00%
23/11 - Closed. Currency in USD ( Disclaimer )
Type:  Equity
Market:  United States
  • Volume: 0
  • Bid/Ask: 8.230 / 8.300
  • Day's Range: 8.180 - 8.250
Adamas Pharmaceuticals Inc 8.220 +0.000 +0.00%

ADMS Recent Sentiments

 
This page contains information on users’ sentiments for the Adamas Pharma stock, which are displayed both on charts of different periods of time and on a detailed table.
Start Date Username Call Open Rate End Date Chg. %
Aug 02, 2023 소룡 이   8.220 Nov 30, 2023 @ 8.220 0.00%
Oct 11, 2021 Natthakitta Sriwiset   8.085 Nov 05, 2021 @ 8.190 +1.30%
Oct 11, 2021 Natthakitta Sriwiset   8.085 Nov 05, 2021 @ 8.190 +1.30%
Oct 11, 2021 Robbert Kuipers   8.065 Nov 05, 2021 @ 8.190 +1.55%
Oct 11, 2021 Robbert Kuipers   8.065 Oct 11, 2021 @ 8.065 0.00%
Oct 11, 2021 KLiir KSA   8.080 Nov 05, 2021 @ 8.190 +1.36%
Oct 11, 2021 Kamo Glen   8.090 Nov 05, 2021 @ 8.190 -1.24%
Oct 11, 2021 menuha waks   8.040 Oct 18, 2021 @ 8.050 +0.12%
Oct 11, 2021 Salim Khizrane   8.030 Oct 18, 2021 @ 8.050 +0.25%
Oct 11, 2021 Sebastien Derrien   8.030 Nov 05, 2021 @ 8.190 +1.99%
Oct 11, 2021 Robbert Kuipers   8.020 Nov 05, 2021 @ 8.190 +2.12%
Oct 11, 2021 Robbert Kuipers   8.020 Oct 11, 2021 @ 8.020 0.00%
Oct 11, 2021 Robbert Kuipers   8.020 Oct 11, 2021 @ 8.020 0.00%
Oct 11, 2021 Marco Introini   8.000 Oct 18, 2021 @ 8.050 -0.63%
Oct 11, 2021 Sayed Gomaa El Atafy   8.000 Nov 05, 2021 @ 8.190 +2.37%
Oct 11, 2021 Tommi Nuutinen   8.040 Nov 05, 2021 @ 8.190 +1.87%
Oct 11, 2021 Tatiana Shuginova   8.010 Oct 11, 2021 @ 8.060 -0.62%
Oct 11, 2021 Kadir Ridak   8.010 Nov 05, 2021 @ 8.190 +2.25%
Oct 11, 2021 SRB R B   7.950 Oct 11, 2021 @ 8.040 +1.13%
Sep 27, 2021 yaron levizon   5.110 Oct 22, 2021 @ 8.010 +56.75%
Aug 17, 2021 yaron levizon   4.310 Sep 10, 2021 @ 4.550 +5.57%
Jul 09, 2021 yaron levizon   5.420 Jul 30, 2021 @ 4.780 -11.81%
May 27, 2021 renato vernini   5.070 Jun 18, 2021 @ 5.380 +6.11%
May 11, 2021 Robbert Kuipers   5.450 Jun 04, 2021 @ 5.140 -5.69%
Mar 01, 2021 Lucia Dandrea   5.030 Mar 26, 2021 @ 5.120 +1.79%
Feb 18, 2021 Bruno Dias   5.920 Mar 12, 2021 @ 5.010 +15.37%
Feb 08, 2021 Karim Barhoumi   6.010 Mar 05, 2021 @ 4.740 -21.13%
Feb 08, 2021 abdulazeez akolade   5.990 Mar 05, 2021 @ 4.740 -20.87%
Feb 05, 2021 Karim Barhoumi   5.920 Feb 05, 2021 @ 6.000 +1.35%
Feb 03, 2021 jun kiat khoo   5.480 Feb 26, 2021 @ 4.750 -13.32%
Feb 02, 2021 Emilio Casati   5.760 Feb 26, 2021 @ 4.750 -17.53%
Feb 02, 2021 Lucia Dandrea   5.500 Feb 26, 2021 @ 4.750 -13.64%
Feb 01, 2021 Joel Larouche   6.730 Feb 26, 2021 @ 4.750 -29.42%
Feb 01, 2021 Alexandre Bavastro   6.800 Feb 26, 2021 @ 4.750 -30.15%
Jan 26, 2021 jose cespedes   5.420 Feb 19, 2021 @ 5.870 +8.30%
Jan 26, 2021 Andres Cutimbo   5.370 Feb 19, 2021 @ 5.870 -9.31%
Jan 26, 2021 Przemek Przybylski   5.440 Feb 19, 2021 @ 5.870 +7.90%
Jan 26, 2021 Angelo Pistilli   5.600 Feb 19, 2021 @ 5.870 +4.82%
Jan 15, 2021 Joshua Manu   4.530 Feb 05, 2021 @ 6.000 +32.45%
Sep 15, 2020 André Bulten   4.380 Oct 09, 2020 @ 4.820 +10.05%
Aug 21, 2020 Jouni   4.570 Sep 11, 2020 @ 4.300 -5.91%
Aug 13, 2020 Jouni   4.680 Aug 13, 2020 @ 0.000 0.00%
Aug 12, 2020 Peter Meško   4.770 Sep 04, 2020 @ 5.370 +12.58%
Aug 10, 2020 Yogesh Surve   4.950 Aug 14, 2020 @ 4.780 +3.43%
Aug 10, 2020 Sameer Rupani   4.970 Sep 04, 2020 @ 5.370 +8.05%
Aug 10, 2020 carmela gazal   5.100 Aug 11, 2020 @ 4.900 +3.92%
Aug 10, 2020 Andreas Schatz   4.910 Sep 04, 2020 @ 5.370 +9.37%
Aug 10, 2020 Agustín García   4.460 Sep 04, 2020 @ 5.370 -20.40%
Aug 10, 2020 Ohad Porat   4.440 Sep 04, 2020 @ 5.370 +20.95%
Aug 07, 2020 Piotr Hombek   3.750 Aug 28, 2020 @ 5.120 +36.53%
Comment Guidelines

We encourage you to use comments to engage with other users, share your perspective and ask questions of authors and each other. However, in order to maintain the high level of discourse we’ve all come to value and expect, please keep the following criteria in mind:  

  •            Enrich the conversation, don’t trash it.

  •           Stay focused and on track. Only post material that’s relevant to the topic being discussed. 

  •           Be respectful. Even negative opinions can be framed positively and diplomatically. Avoid profanity, slander or personal attacks directed at an author or another user. Racism, sexism and other forms of discrimination will not be tolerated.

  • Use standard writing style. Include punctuation and upper and lower cases. Comments that are written in all caps and contain excessive use of symbols will be removed.
  • NOTE: Spam and/or promotional messages and comments containing links will be removed. Phone numbers, email addresses, links to personal or business websites, Skype/Telegram/WhatsApp etc. addresses (including links to groups) will also be removed; self-promotional material or business-related solicitations or PR (ie, contact me for signals/advice etc.), and/or any other comment that contains personal contact specifcs or advertising will be removed as well. In addition, any of the above-mentioned violations may result in suspension of your account.
  • Doxxing. We do not allow any sharing of private or personal contact or other information about any individual or organization. This will result in immediate suspension of the commentor and his or her account.
  • Don’t monopolize the conversation. We appreciate passion and conviction, but we also strongly believe in giving everyone a chance to air their point of view. Therefore, in addition to civil interaction, we expect commenters to offer their opinions succinctly and thoughtfully, but not so repeatedly that others are annoyed or offended. If we receive complaints about individuals who take over a thread or forum, we reserve the right to ban them from the site, without recourse.
  • Only English comments will be allowed.
  • Any comment you publish, together with your investing.com profile, will be public on investing.com and may be indexed and available through third party search engines, such as Google.

Perpetrators of spam or abuse will be deleted from the site and prohibited from future registration at Investing.com’s discretion.

ADMS Comments

Write your thoughts about Adamas Pharma
 
Are you sure you want to delete this chart?
 
Post
Post also to:
 
Replace the attached chart with a new chart ?
1000
Your ability to comment is currently suspended due to negative user reports. Your status will be reviewed by our moderators.
Please wait a minute before you try to comment again.
Thanks for your comment. Please note that all comments are pending until approved by our moderators. It may therefore take some time before it appears on our website.
PlanetApe Ape
PlanetApe Ape Oct 11, 2021 9:01AM ET
Saved. See Saved Items.
This comment has already been saved in your Saved Items
Juat in: Supernus Pharma To Acquire Adamas Pharma For Total Consideration Up To $9.10/shr
SS SS
SS SS Jun 05, 2020 12:32PM ET
Saved. See Saved Items.
This comment has already been saved in your Saved Items
Adamas ? is it worths to entry ?
Raffael Cavaliere
Raffael Cavaliere Sep 19, 2018 12:27PM ET
Saved. See Saved Items.
This comment has already been saved in your Saved Items
Pressure to discuss the sale of the company seems to be growing up. https://chn.ge/2OEI2kD
Joel Hanson
Joel Hanson Nov 17, 2016 11:36AM ET
Saved. See Saved Items.
This comment has already been saved in your Saved Items
All 8 analyst covering ADMS recommend "buy." The average target price consensus for the next 12 months is $34 which is 110% ROI at its current price of $16.16.
Joe Mingoia
Joe Mingoia Nov 17, 2016 11:36AM ET
Saved. See Saved Items.
This comment has already been saved in your Saved Items
revenue is going to increase exponentially once this parkinsons drug gets out in circulation in January 18 .. that will be good for top and bottom line numbers come earning seasons.$$$$$. and mist of all definitely great for patients suffering.
Krypto Nite
Krypto Nite Nov 17, 2016 11:36AM ET
Saved. See Saved Items.
This comment has already been saved in your Saved Items
Huh, so price targets me nothing. The more you know (it's not getting anywhere near $30 in the next 3 months)
 
Are you sure you want to delete this chart?
 
Post
 
Replace the attached chart with a new chart ?
1000
Your ability to comment is currently suspended due to negative user reports. Your status will be reviewed by our moderators.
Please wait a minute before you try to comment again.
Add Chart to Comment
Confirm Block

Are you sure you want to block %USER_NAME%?

By doing so, you and %USER_NAME% will not be able to see any of each other's Investing.com's posts.

%USER_NAME% was successfully added to your Block List

Since you’ve just unblocked this person, you must wait 48 hours before renewing the block.

Report this comment

I feel that this comment is:

Comment flagged

Thank You!

Your report has been sent to our moderators for review
Continue with Google
or
Sign up with Email